Theravance Biopharma, Inc. (TBPH)
20.00
-0.10
(-0.52%)
USD |
NASDAQ |
Jan 16, 16:00
20.98
+0.98
(+4.87%)
After-Hours: 20:00
Theravance Biopharma SG&A Expense (TTM): 75.94M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 401.86M |
| Perspective Therapeutics, Inc. | 31.53M |
| Skye Bioscience, Inc. | 16.93M |
| Kyntra Bio, Inc. | 28.80M |
| Myomo, Inc. | 32.71M |